강원대학교 생물공학과

교수진

  • 홍억기 교수님
  • 허원 교수님
  • 최신건 교수님
  • 하석진 교수님
  • 임광석 교수님
  • 박희호 교수님
  • 김현욱 교수님

박희호 교수님

홈 > 교수진 > 박희호 교수님

박희호 교수님 (Park, Hee Ho)

사진

학 력
  • 2007. Imperial College London (공학 학/석사 MEng - Department of Chemical Engineering)
  • 2014. 서울대학교 (공학박사 - 화학생물공학부)
주요경력
  • 2014.10~2016.04 : 서울대학교, 유전공학연구소 (박사후연구원)
  • 2016.05~2018.02 : Harvard Medical School, Division of Hematology/Oncology (Postdoctoral Research Fellow)
연구분야
  • 항체 및 단백질 나노입자
  • 면역세포치료제
  • 줄기세포공학
  • CRISPR 유전자 편집
  • 바이러스
  • 인공육

 

최근주요 연구실적
  • Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm (2021, Nano Today)

  • PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses (2021, Biomaterials)

  • Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm (2021, Nano Today)

  • 2D graphene oxide particles induce unwanted loss in pluripotency and trigger early differentiation in human pluripotent stem cells (2021, Journal of Hazardous Materials)

  • Stem cell-derived exosomes and nanovesicles: Promotion of cell proliferation, migration and anti-senescence for treatment of wound damage and skin ageing (2020, Pharmaceutics)

  • Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm (2020, Biomaterials)

  • Direct conversion of human fibroblasts into osteoblasts triggered by histone deacetylase inhibitor valproic acid (2020, Applied Sciences)

  • Bioinspired DNase-I-coated melanin-like nanospheres for modulation of infection-associated NETosis dysregulation (2020, Advanced Science)

  • Ferritin nanocage-based methyltransferase SETD6 for COVID-19 therapy (2020, Advanced Functional Materials)

  • COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm (2020, Signal Transduction and Targeted Therapy)

  • Wnt5a and Wnt11 as acute respiratory distress syndrome biomarkers for SARS-CoV-2 patients (2020, European Respiratory Journal)

  • Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia (2020, Science Advances)

  • Protein-based nanoparticles as drug delivery systems (2020, Pharmaceutics)

  • Protein-based direct reprogramming of fibroblasts to neuronal lineage cells (2020, International Journal of Biochemistry & Cell Biology)
  • Enhanced single-cell viability using 30Kc6 for efficient expansion of human induced pluripotent stem cells (2019, Process Biochemistry)
  • DROSHA knockout leads to enhancement of viral titers for vectors encoding miRNA adapted shRNAs (shRNAmiRs) (2018, Molecular Therapy-Nucleic Acids)
  • Efficient encapsulation and sustained release of basic fibroblast growth factor in nanofilm: extension of the feeding cycle of human induced pluripotent stem cell culture (2017, ACS Applied Materials and Interfaces)
  • Multilayer nanofilms via inkjet printing for stabilizing growth factor and designing desired cell developments (2017, Advanced Healthcare Materials) 
  • Alpha-galactosidase delivery using 30Kc19-human serum albumin nanoparticles for effective treatment of Fabry disease (2016, Applied Microbiology and Biotechnology) 

  • Enhancement of human erythropoietin production in Chinese hamster ovary cells through supplementation of 30Kc19-30Kc6 fusion protein (2015, Process Biochemistry)